Chemoinformaics analysis of 2H-Pyran-2-one, 4-methoxy-6-(2-phenylethyl)-
Molecular Weight | 230.263 | nRot | 4 |
Heavy Atom Molecular Weight | 216.151 | nRig | 13 |
Exact Molecular Weight | 230.094 | nRing | 2 |
Solubility: LogS | -3.215 | nHRing | 1 |
Solubility: LogP | 2.728 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
nHA | 3 | APOL | 35.1211 |
nHD | 0 | BPOL | 18.3849 |
QED | 0.809 |
Synth | 1.976 |
Natural Product Likeliness | 0.618 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.96 |
Pgp-sub | 0.016 |
HIA | 0.007 |
CACO-2 | -4.745 |
MDCK | 0.0000172 |
BBB | 0.232 |
PPB | 0.955846 |
VDSS | 0.834 |
FU | 0.0144816 |
CYP1A2-inh | 0.961 |
CYP1A2-sub | 0.954 |
CYP2c19-inh | 0.964 |
CYP2c19-sub | 0.311 |
CYP2c9-inh | 0.764 |
CYP2c9-sub | 0.905 |
CYP2d6-inh | 0.161 |
CYP2d6-sub | 0.888 |
CYP3a4-inh | 0.193 |
CYP3a4-sub | 0.429 |
CL | 10.14 |
T12 | 0.657 |
hERG | 0.236 |
Ames | 0.053 |
ROA | 0.099 |
SkinSen | 0.52 |
Carcinogencity | 0.319 |
EI | 0.961 |
Respiratory | 0.157 |
NR-Aromatase | 0.021 |
Antiviral | No |
Prediction | 0.713731 |